Percutaneous coronary intervention and adjunctive pharmacotherapy in women - A statement for healthcare professionals from the American Heart Association

Review

关键词: ACUTE MYOCARDIAL-INFARCTION;    GLYCOPROTEIN IIB/IIIA BLOCKADE;    IN-HOSPITAL MORTALITY;    PRACTICE GUIDELINES COMMITTEE;    SEX-BASED DIFFERENCES;    UNSTABLE ANGINA;    GENDER-DIFFERENCES;    CLINICAL-OUTCOMES;    BALLOON ANGIOPLASTY;    RANDOMIZED-TRIAL;   

DOI  :  10.1161/01.CIR.0000155337.50423.C9

来源: SCIE

【 摘 要 】

More than 1.2 million percutaneous coronary interventions are performed annually in the United States, with only an estimated 33% performed in women, despite the established benefits of percutaneous coronary intervention and adjunctive pharmacotherapy in reducing fatal and nonfatal ischemic complications in acute myocardial infarction and high-risk acute coronary syndromes. This statement reviews sex-specific data on the safety and efficacy of contemporary interventional therapies in women.

【 授权许可】

Free